Medtronicvs.ResMed
MDT vs RMD · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Medtronic is about 3.6× larger than ResMed by market cap; ResMed trades at the lower P/E (21.5 vs 24.2).
Side by side
| MDT | RMD | |
|---|---|---|
| Market cap | $116B | $32.7B |
| Price | $91.14 | $236.59 |
| Today | −1.9% | +1.8% |
| Return YTD | −3.3% | −3.5% |
| Return 1Y | +0.2% | −20.9% |
| P/E | 24.2 | 21.5 |
| P/S | 3.2 | 5.8 |
| P/B | 2.4 | 5.0 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
MedtronicMDT
Cardiac rhythm and cardiology devices anchor a catalogue that also runs through surgical equipment, neurology and diabetes treatment.
Full MDT profile →ResMedRMD
CPAP machines and masks for sleep apnea, sold with cloud software, next to a wider respiratory equipment range.
Full RMD profile →More MDT & RMD comparisons
Other head-to-heads in the Medtech & devices segment.
See where MDT and RMD sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →